Citation:Murray KJ, Scott C, Greenberg HM, Emami B, Seider M, Vora NL, et al 1997

From Cancer Guidelines Wiki

Citation


Murray KJ, Scott C, Greenberg HM, Emami B, Seider M, Vora NL, et al. A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104. Int J Radiat Oncol Biol Phys 1997 Oct 1;39(3):571-4 Available from: http://www.ncbi.nlm.nih.gov/pubmed/9336134.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Murray KJ, Scott C, Greenberg HM, Emami B, Seider M, Vora NL, et al 1997What is the clinical benefit of radiotherapy to the brain for patients with inoperable brain metastases from NSCLC?Associate Professor Shalini Vinod MBBS MD FRANZCRcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What is the clinical benefit of radiotherapy to the brain for patients with inoperable brain metastases from NSCLC?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the clinical benefit of radiotherapy to the brain for patients with inoperable brain metastases from NSCLC?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. What is the clinical benefit of radiotherapy to the brain for patients with inoperable brain metastases from NSCLC?
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Murray_KJ,_Scott_C,_Greenberg_HM,_Emami_B,_Seider_M,_Vora_NL,_et_al_1997&oldid=21454"